EUVIMEDEUVIMED entdecken
Crossref

Association Between NAT2 Polymorphisms and Prostate Cancer

Mandana Hasanzad, Seyed Amir Mohsen Ziaei, Vahideh Montazeri, Mahdi Afshari, Seyed Hamid Jamaldini, Mahdieh Imani, Mahshid Sattari, Leila Hashemian, Seyed Rouhollah Kalantar Moaetamed, Mohammad Samzadeh

Iranian Journal of Cancer Prevention · 14.02.2017 · In Press (In Press)

DOI: 10.5812/ijcp.5716 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iranian Journal of Cancer Prevention, online erschienen am 14.02.2017. Verfasst von Mandana Hasanzad und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hasanzad, M., Ziaei, S. A. M., Montazeri, V., Afshari, M., Jamaldini, S. H., Imani, M., Sattari, M., Hashemian, L., Moaetamed, S. R. K., & Samzadeh, M. (2017). Association Between NAT2 Polymorphisms and Prostate Cancer. Iranian Journal of Cancer Prevention, In Press(In Press). https://doi.org/10.5812/ijcp.5716

Vancouver

Hasanzad M, Ziaei SAM, Montazeri V, Afshari M, Jamaldini SH, Imani M, et al. Association Between NAT2 Polymorphisms and Prostate Cancer. Iranian Journal of Cancer Prevention. 2017;In Press(In Press). doi:10.5812/ijcp.5716

BibTeX
@article{Hasanzad2017,
  author = {Hasanzad, Mandana and Ziaei, Seyed Amir Mohsen and Montazeri, Vahideh and Afshari, Mahdi and Jamaldini, Seyed Hamid and Imani, Mahdieh and Sattari, Mahshid and Hashemian, Leila and Moaetamed, Seyed Rouhollah Kalantar and Samzadeh, Mohammad},
  title = {Association Between NAT2 Polymorphisms and Prostate Cancer},
  journal = {Iranian Journal of Cancer Prevention},
  year = {2017},
  volume = {In Press},
  number = {In Press},
  doi = {10.5812/ijcp.5716}
}
Kostenlos starten →